急性缺血性卒中患者住院期间患肺炎与近期及远期死亡风险研究

2013-07-11 MedSci MedSci原创

目的探讨急性脑梗死患者住院期间患肺炎与其近期及远期预后的关系。方法收集2007年9月至2008年8月中国多省市132家研究中心所有>18岁 急性脑梗死入组患者有关肺炎、出院结局、发病后3、6和12个月结局,其他相关信息由纸质登记表获得。采用多元logistic回归分析住院期间肺炎与急 性脑梗死患者预后的关系。结果11560例急性脑梗死患者中1373例(11.88%)患者发生住院期间肺炎,

目的探讨急性脑梗死患者住院期间患肺炎与其近期及远期预后的关系。方法收集2007年9月至2008年8月中国多省市132家研究中心所有>18岁 急性脑梗死入组患者有关肺炎、出院结局、发病后3、6和12个月结局,其他相关信息由纸质登记表获得。采用多元logistic回归分析住院期间肺炎与急 性脑梗死患者预后的关系。结果11560例急性脑梗死患者中1373例(11.88%)患者发生住院期间肺炎,急性脑梗死患者发病后12个月总病死率为 14.4%(1664例),罹患肺炎患者病死率高于未患肺炎患者;住院期间肺炎是患者住院期间(OR5.916,95%CI4.470~7.831)、发病后3个月(OR3.641,95%CI3.035~4.367)、6个月(OR3.445,95%CI2.905~4.086)和12个月(OR3.543,95%CI3.016~4.161)死亡的独立危险因素。结论住院期间肺炎增加急性脑梗死患者近期及远期死亡的风险。

原始出处:王蓬莲,赵性泉,王伊龙等. 急性缺血性卒中患者住院期间患肺炎与近期及远期死亡风险研究[J]. 中华内科杂志, 2013, 52(7): 554-556.
全文下载急性缺血性卒中患者住院期间患肺炎与近期及远期死亡风险研究.pdf

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2055586, encodeId=38a42055586bd, content=<a href='/topic/show?id=734110089320' target=_blank style='color:#2F92EE;'>#风险研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100893, encryptionId=734110089320, topicName=风险研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Dec 17 07:34:00 CST 2013, time=2013-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720003, encodeId=50321e20003bd, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Apr 04 04:34:00 CST 2014, time=2014-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805972, encodeId=ebf718059e273, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Mon Feb 17 09:34:00 CST 2014, time=2014-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010317, encodeId=97d6201031e17, content=<a href='/topic/show?id=9cf7e9360d2' target=_blank style='color:#2F92EE;'>#缺血性卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79360, encryptionId=9cf7e9360d2, topicName=缺血性卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Thu Aug 29 20:34:00 CST 2013, time=2013-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892580, encodeId=d6c418925809b, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Jun 19 21:34:00 CST 2014, time=2014-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255447, encodeId=13f6125544e4c, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Jul 13 13:34:00 CST 2013, time=2013-07-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2055586, encodeId=38a42055586bd, content=<a href='/topic/show?id=734110089320' target=_blank style='color:#2F92EE;'>#风险研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100893, encryptionId=734110089320, topicName=风险研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Dec 17 07:34:00 CST 2013, time=2013-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720003, encodeId=50321e20003bd, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Apr 04 04:34:00 CST 2014, time=2014-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805972, encodeId=ebf718059e273, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Mon Feb 17 09:34:00 CST 2014, time=2014-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010317, encodeId=97d6201031e17, content=<a href='/topic/show?id=9cf7e9360d2' target=_blank style='color:#2F92EE;'>#缺血性卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79360, encryptionId=9cf7e9360d2, topicName=缺血性卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Thu Aug 29 20:34:00 CST 2013, time=2013-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892580, encodeId=d6c418925809b, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Jun 19 21:34:00 CST 2014, time=2014-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255447, encodeId=13f6125544e4c, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Jul 13 13:34:00 CST 2013, time=2013-07-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2055586, encodeId=38a42055586bd, content=<a href='/topic/show?id=734110089320' target=_blank style='color:#2F92EE;'>#风险研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100893, encryptionId=734110089320, topicName=风险研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Dec 17 07:34:00 CST 2013, time=2013-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720003, encodeId=50321e20003bd, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Apr 04 04:34:00 CST 2014, time=2014-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805972, encodeId=ebf718059e273, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Mon Feb 17 09:34:00 CST 2014, time=2014-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010317, encodeId=97d6201031e17, content=<a href='/topic/show?id=9cf7e9360d2' target=_blank style='color:#2F92EE;'>#缺血性卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79360, encryptionId=9cf7e9360d2, topicName=缺血性卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Thu Aug 29 20:34:00 CST 2013, time=2013-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892580, encodeId=d6c418925809b, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Jun 19 21:34:00 CST 2014, time=2014-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255447, encodeId=13f6125544e4c, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Jul 13 13:34:00 CST 2013, time=2013-07-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2055586, encodeId=38a42055586bd, content=<a href='/topic/show?id=734110089320' target=_blank style='color:#2F92EE;'>#风险研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100893, encryptionId=734110089320, topicName=风险研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Dec 17 07:34:00 CST 2013, time=2013-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720003, encodeId=50321e20003bd, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Apr 04 04:34:00 CST 2014, time=2014-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805972, encodeId=ebf718059e273, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Mon Feb 17 09:34:00 CST 2014, time=2014-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010317, encodeId=97d6201031e17, content=<a href='/topic/show?id=9cf7e9360d2' target=_blank style='color:#2F92EE;'>#缺血性卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79360, encryptionId=9cf7e9360d2, topicName=缺血性卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Thu Aug 29 20:34:00 CST 2013, time=2013-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892580, encodeId=d6c418925809b, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Jun 19 21:34:00 CST 2014, time=2014-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255447, encodeId=13f6125544e4c, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Jul 13 13:34:00 CST 2013, time=2013-07-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2055586, encodeId=38a42055586bd, content=<a href='/topic/show?id=734110089320' target=_blank style='color:#2F92EE;'>#风险研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100893, encryptionId=734110089320, topicName=风险研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Dec 17 07:34:00 CST 2013, time=2013-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720003, encodeId=50321e20003bd, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Apr 04 04:34:00 CST 2014, time=2014-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805972, encodeId=ebf718059e273, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Mon Feb 17 09:34:00 CST 2014, time=2014-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010317, encodeId=97d6201031e17, content=<a href='/topic/show?id=9cf7e9360d2' target=_blank style='color:#2F92EE;'>#缺血性卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79360, encryptionId=9cf7e9360d2, topicName=缺血性卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Thu Aug 29 20:34:00 CST 2013, time=2013-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892580, encodeId=d6c418925809b, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Jun 19 21:34:00 CST 2014, time=2014-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255447, encodeId=13f6125544e4c, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Jul 13 13:34:00 CST 2013, time=2013-07-13, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2055586, encodeId=38a42055586bd, content=<a href='/topic/show?id=734110089320' target=_blank style='color:#2F92EE;'>#风险研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100893, encryptionId=734110089320, topicName=风险研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Dec 17 07:34:00 CST 2013, time=2013-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720003, encodeId=50321e20003bd, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Fri Apr 04 04:34:00 CST 2014, time=2014-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805972, encodeId=ebf718059e273, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Mon Feb 17 09:34:00 CST 2014, time=2014-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2010317, encodeId=97d6201031e17, content=<a href='/topic/show?id=9cf7e9360d2' target=_blank style='color:#2F92EE;'>#缺血性卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79360, encryptionId=9cf7e9360d2, topicName=缺血性卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Thu Aug 29 20:34:00 CST 2013, time=2013-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892580, encodeId=d6c418925809b, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Thu Jun 19 21:34:00 CST 2014, time=2014-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255447, encodeId=13f6125544e4c, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Jul 13 13:34:00 CST 2013, time=2013-07-13, status=1, ipAttribution=)]

相关资讯

[OCC2013]稳定型冠心病的诊断策略:斑块稳定并非病情稳定

张大东教授:急性缺血性卒中伴冠心病患者的血压问题是一直讨论比较热烈的话题,对于血压的水平控制在什么情况下是最好的,国内外讨论非常多。血压降得比较低一点呢,对有利于缓解卒中病情,但有可能恶化心功能。我个人认为对于这类患者,血压控制在130 mm Hg可能比较好,对于脑卒中患者,有效控制血压有利于脑卒中病情改善,如果低于血压低于120mm Hg实际上不利于脑卒中,我们把血压控制在130/80~85 m

Stroke:缺血性卒中后慢性疼痛综合征常见

        一项多国联合研究表明,缺血性卒中后慢性疼痛综合征较为常见,并且与功能依赖增加和认知减退相关。论文于4月4日在线发表于《卒中》(Stroke)。   此项研究从平均随访2.5年的PRoFESS试验中共纳入15754例受试者。利用标准化慢性疼痛调查问卷对卒中后报告慢性疼痛并且索引卒中前无慢性疼痛病史的所有受试者加以评估。利用多变量Logistic回归分析确定卒中后疼痛和疼痛亚型的

Stroke:阵发性室上性心动过速与缺血性卒中独立相关

  美国一项研究表明,阵发性室上性心动过速(PSVT)与缺血性卒中呈独立相关,PSVT可能为卒中的新型危险因素。论文4月30日在线发表于《卒中》(Stroke)。   此项回顾性队列研究利用急诊和住院保险索赔资料确认了相关患者。主要暴露指标为卒中发生前或卒中就诊时伴有PSVT诊断。排除伴有房颤诊断的患者亦减少混淆。利用ICD-9确定PSVT、卒中和房颤。   结果显示,共有4806830例适宜

Am J Cardiol:急性冠脉综合征和缺血性卒中危险因素相似

  希腊一项研究表明,急性冠脉综合征和缺血性卒中的相关危险因素基本相似,因此有有利于同时实施一级预防措施。论文4月29日在线发表于《美国心脏病学杂志》(Am J Cardiol)。   此项研究共纳入250例首次急性冠脉综合征患者、250例首次缺血性卒中患者以及500例基于人群的对照者;以1:1比率依据年龄和性别配对。对吸烟/被动吸烟、心血管疾病家族史、无体育活动、高血压、糖

Lancet Neurol:缺血性卒中患者预防性使用肝素治疗并未获益

血栓栓塞性事件及出血性事件的预测模型 一直以来,有高凝状态的卒中患者推荐使用肝素预防血栓栓塞性事件。很多国际卒中治疗也推荐,对于静脉血栓形成高危或低出血风险的卒中患者使用肝素预防血栓形成。但治疗效果尚不明确,来自英国的William N Whiteley 等医师汇总了卒中治疗方面的几项大型临床试验,其目的是确定选择抗凝治疗的可靠方法,从而降低卒中死亡率及重度残疾状态。研究结果发表在2013年5月

Am J Cardiol:急性冠脉综合征和缺血性卒中危险因素相似

  希腊一项研究表明,急性冠脉综合征和缺血性卒中的相关危险因素基本相似,因此有有利于同时实施一级预防措施。论文4月29日在线发表于《美国心脏病学杂志》(Am J Cardiol)。   此项研究共纳入250例首次急性冠脉综合征患者、250例首次缺血性卒中患者以及500例基于人群的对照者;以1:1比率依据年龄和性别配对。对吸烟/被动吸烟、心血管疾病家族史、无体育活动、高血压、糖